Clinical trials recruiting in Douliu, Taiwan

Phase breakdown

Conditions recruiting in Douliu, Taiwan

Recruiting trials in Douliu, Taiwan

• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
  NCT06119581 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
  NCT06757634 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
  NCT07283887 · Phase: Phase 4 · Ages: 50 Years to 80 Years · Sex: Female
• Step-down Therapy After Long-term Osteoporosis Treatment
  NCT07281586 · Phase: Phase 4 · Ages: 50 Years to 85 Years · Sex: All (male and female)
• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
  NCT06890598 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder
  NCT05161819 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 70 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Douliu, Taiwan?

6 recruiting trials have at least one study site in Douliu, Taiwan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.